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A B S T R A C T
Purpose: In response to continuing concerns regarding the quality and equality of care for children and
young people, the British Paediatric Neurology Association (BPNA) has supported the development of
practical and meaningful audit to support quality improvement.
Method: In 2006, the Children’s Epilepsy Workstream in Trent (CEWT) coordinated a retrospective
multi-service audit of paediatric epilepsy care against NICE and SIGN guidelines. This aimed to both
facilitate quality improvements for participating services and act as a pilot for future potential national
audits.
Results: The audit was achieved in 4 hospital services using prospective and retrospective ascertainment
methods. 12 performance indicators were applied to each cohort. Overall 54% (12/22) of children with
epilepsy had input from a paediatrician with ‘‘expertise’’ and 23% (5/22) had input from an epilepsy
specialist nurse.
Conclusion: Audit can be developed for epilepsies that delivers standardised quality metrics against
national recommendations. As well as supporting local quality improvement initiatives, comparative
and aggregate data can be produced to potentially give regional and national perspectives. The results
and experience describe the journey towards the 2009–2012 Epilepsy12 UK multicentre epilepsy audit.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Epilepsies are the commonest disabling chronic neurological
disorders of childhood with a prevalence of approximately 1 in 200
children and an incidence of 50–80 per 100 000 per year.1,2 In the
UK, the majority of children are diagnosed and managed in acute
and non-acute secondary level paediatric services with some
requiring additional paediatric neurology (tertiary) involvement.
There has been longstanding concern regarding misdiagnosis and
quality of management.3
National recommendations for investigation and management
of epilepsies were introduced in 2004,1,2,4 however meaningful
audit against these standards has been difﬁcult.5* Corresponding author at: Department of Paediatrics, King’s Mill Hospital,
Sutton in Ashﬁeld, NG17 4JL, UK. Tel.: +44 01623 622 515.
E-mail address: colin.dunkley@sfh-tr.nhs.uk (C. Dunkley).
http://dx.doi.org/10.1016/j.seizure.2014.04.004
1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reThe Children’s Epilepsy Workstream in Trent (CEWT) was
established to support epilepsy service development in the
Mid-Trent region. In 2006, the British Paediatric Neurology
Association (BPNA) commissioned CEWT to coordinate a regional
audit pilot to assess the quality of epilepsy care and service
provision across Trent.
This paper outlines the journey and evolution of methodologies
leading ultimately to the ongoing Epilepsy12 UK national audit.
2. Methods
All paediatricians within the Mid-Trent region were invited
to participate. Audit coordinators (Epilepsy Nurse Specialist,
Senior House Ofﬁcer or Specialist Registrar) were identiﬁed at
each participating service. One Specialist Registrar acted as
regional co-ordinator and one Paediatric Consultant acted as
clinical lead.served.
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 assessed for the ﬁrst time by a paediatric service with a
paroxysmal episode(s) within a deﬁned ten week time period;
 the episode(s) were considered by referrer or assessor to be of a
possible epileptic nature.
Children with a diagnosis of febrile convulsions were excluded.
No single ascertainment method was found to be achievable
and therefore ascertainment strategies were tailored to each
individual participating service. The closest 10 week period to a
time period ending at the end of June 2004, where ascertainment
was possible and records were available, was selected.
Service 1 – Windows-based keyword search (‘‘seizure’’,
‘‘convulsion’’, ‘‘ﬁt’’, ‘‘epilep*’’) of archived hospital clinic letters
during the deﬁned time period and ward admission records.
Service 2 – General Practitioner referrals to outpatient general
paediatricians (data from previous local audit6) and keyword
search of emergency department records.
Service 3 – Keyword search of acute admissions coding and
outpatient letters (data from 2 consultants only available)
Service 4 – Windows-based keyword search of archived
outpatient letters
The case notes were obtained based on these initial search
strategies. First paediatric assessment was deﬁned as either the
ﬁrst outpatient appointment or the ﬁrst acute paediatric assess-
ment/admission. The time period examined was 12 months
following the ﬁrst paediatric assessment. Clinical information
was obtained from handwritten casenotes, typed clinic letters and
discharge summaries.
Proformas based on BPNA previous audit tools7were completed
for each child meeting the inclusion criteria. The diagnosis made by
the paediatric service at ﬁrst presentation and at the latest
assessment 12 months after ﬁrst assessment was determined.
Diagnoses were categorised as epileptic, non-epileptic or uncer-
tain. A number of seizures occurring within a 24 h period were
interpreted as a single episode or seizure cluster rather than
recurrent seizures. Epilepsy was deﬁned as diagnosed where the
documentation showed evidence of diagnosing recurrent epileptic
episodes. Data was anonymised and entered into a centralised
Microsoft Excel spreadsheet. Data validation and measures of
inter-observer variability were not undertaken; this was under-
taken within the subsequent national Epilepsy12 audit.8
Twelve clinical performance indicators derived from NICE and
SIGN recommendations were applied.1,2,4 The performance indi-
cators were designed on the basis of the following criteria:
 standard deﬁned by national guidance
 performance indicator could be calculated using retrospective
casenote analysisTable 1
Summary of the methodology and numbers included for each cohort.
All Cohort 1 
Date of ﬁrst assessment 2004–2005 21/4/04-30/6/04 
Location of service District General 
% general paediatricians in
audit for area covered
58% (31/53) 71% (5/7) 
Ascertainment method Coding database
& keyword
Inclusion criteria afebrile seizures afebrile seizures 
No. identiﬁed 236 37 
Notes unavailable 11 0 
Excluded on entry criteria 160 19 
N 65 18  performance indicators could be meaningfully applied to
multiple heterogenous cohorts to facilitate comparative analysis
 results could be translated into a pragmatic service quality
improvement agenda
The audit was conducted between March and December 2006.
3. Results
Four hospital based services responded and registered the
audit. Cohort 4 contained children presenting 17 months after
cohort 1–3. NICE recommendations were published during
the time period examined for cohort 1–3 and before that for
cohort 4.
The initial search methods identiﬁed 236 children. Case notes
were available for 225 and of these 160 were excluded using stated
criteria. Total number included was 65 (Table 1).
The median age at presentation was 6.5 years; 48% were
female (Table 2). Learning difﬁculty was deﬁned as present if
referred to in the notes or that the child had a diagnosis of global
developmental delay. 56% of children had their ﬁrst assessment
in a paediatric clinic setting and 44% in an acute paediatric
setting.
22 children had a diagnosis of epilepsy by 1 year of which 12
were commenced on antiepileptic medication (Fig. 1).
The results for each performance indicator (PI) are sum-
marised in Table 3.
PI1: 54% of children diagnosed with epilepsy had evidence of
input by a paediatrician with expertise in epilepsy (Table 4). For
this pilot, ‘‘paediatrician with expertise’’ was deﬁned as those
consultant paediatricians who declared an interest or expertise in
epilepsies during a previous Trent scoping survey.
PI2: 23% diagnosed with epileptic seizures in 1st year had
evidence of referral to, or involvement of, an epilepsy nurse by 1
year. Any evidence of hospital casenote documented referral or
contact during the ﬁrst year was accepted.
PI3: A ﬁrst clinical assessment was deﬁned as appropriate if it
contained any key features. *46% had of evidence of an appropriate
ﬁrst clinical assessment.
PI4: 100% of children commenced on antiepileptic drugs (AEDs)
at any time in the ﬁrst year had a diagnosis of epileptic seizures at 1
year.
PI5: 81% diagnosed as epileptic seizure(s) in 1st year had
seizure classiﬁcation by 1 year. Any attempt at seizure classiﬁca-
tion was accepted including ‘unclassiﬁed’.
PI6: 50% diagnosed as having epileptic seizures (not including
single epileptic seizure or seizure cluster) had syndromal or
syndromal category classiﬁcation by 1 year. Any attempt
at epilepsy syndrome classiﬁcation was accepted including
‘unclassiﬁed’.Cohort 2 Cohort 3 Cohort 4
21/4/04-30/6/04 26/4/04-5/7/04 1/9/05-10/11/05
District General Tertiary Hospital District General
83% (5/6) 48% (11/23) 59% (10/17)
Coding database & keyword Coding database
& GP letters
Keyword
afebrile seizures afebrile seizures afebrile seizures
16 145 38
0 9 2
8 122 11
8 14 25
Table 2
Demographic details for the cohorts ascertained.
All Cohort 1 Cohort 2 Cohort 3 Cohort 4
Median age in years (range) 6.5 (0–16.9) 6.7 (0.4–14.5) 8.5 (3–12) 2.9 (0–14.9) 8.1(0.1–16.9)
Female:male (%) 48:52 67:33 38:63 21:79 64:36
Learning difﬁculty (%) 7% 6% 13% 0% 8%
First assessment outpatient: acute (%) 56:44 89:11 25:75 14:86 96:4
epilepc 
seizure(s) 
, 29,  45 %
non-
epilepc 
seizures, 
21, 32 %
uncertain
, 15,  23 %
>1 
epilepc 
seizures, 
22, 34 %
single 
epilepc 
seizures, 
10, 15 %
non-
epilepc 
seizures, 
26, 40 %
uncer tain, 
7, 11 %
Fig. 1. Pie charts showing diagnoses at ﬁrst assessment (left) and at 1 year (right).
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did not have EEG at ﬁrst assessment. Conversely 10% children had
EEG where the diagnosis at ﬁrst assessment was non-epileptic.
PI8: 71% with epileptic seizures at 1 year with an indication for
MRI, had MRI by 1 year. Indications used for this audit were age less
than two at onset of seizures or diagnosis of a focal epilepsy other
than rolandic epilepsy.
PI9: 23% with convulsive episodes of uncertain cause at 1 year
or diagnosed as syncope had a 12 lead ECG by 1 year.
PI10: 0% females older than 12 years commenced on AEDs had
documented evidence of discussion regarding pregnancy related
issues.
PI11: 25% commenced on anti-epileptic drugs (AEDs) had
documented evidence of discussion regarding adverse effects.
PI12: 100% diagnosed epileptic seizures meeting NICE referral
criteria had evidence of referral to or discussion with tertiary care
by 1 year.Table 3
12 Performance indicators and subset indicators for each cohort and overall.
No. Performance indicator (PI) All 
1 Input from paediatrician with expertise 54% (12/22) 
2 Contact with Epilepsy Nurse Specialist 23% (5/22) 
3 Appropriate* First Clinical Assessment 46% (30/65) 
Age at onset* 97% (63/65)
Description of events* 98% (64/65)
Duration of events 92% (60/65)
Frequency of events* 97% (63/65)
Provoking or relieving factors enquiry 73% (48/65)
Family History enquiry 82% (53/65)
Past Medical History enquiry 94% (61/65)
Development/School Performance (if >5yr)* 55% (36/65)
General and neurological examination* 98% (64/65)
4 AEDs only for epilepsy 100% (12/12) 
5 Epileptic Seizure(s) classiﬁed 81% (26/32) 
% seizure type used recognised by ILAE 92% (24/26) 
6 Epilepsy Syndrome classiﬁed 50% (11/22) 
% syndromes used recognised by ILAE 82% (9/11) 
7 Absence inappropriate EEG 90% (19/21) 
8 MRI where appropriate 71% (5/7) 
9 ECG where appropriate 23% (3/13) 
10 Discussion pregnancy and AEDs 0% (0/1) 
11 Discussion adverse effects and AEDs 25% (3/12) 
12 Neurology referral where appropriate 100% (2/2) 
* Indicates clinical information needed to deﬁne clinical assessment as appropriate.Waiting times were determined from the time of referral to the
time ﬁrst appointment offered or acute assessment. 48% of
children referred after a non-febrile seizure were seen within
the NICE recommendation of 2 weeks.
4. Audit conclusions
Within this pilot no single ascertainment method could be
applied consistently. Methods used depended on local systems for
tracking admissions and outpatient encounters. The cohort for each
centre was deﬁned as being within a 10 week period but again due to
the different methods used at each centre the same 10 week period
was not used for each cohort. Because outpatient and community
paediatric services did not permit any reliable way of identifying
patients with epilepsy there was no gold standard to measure
ascertainment completeness. Cohort 4 did not include those children
initially admitted acutely. Therefore some sampling bias may have
been introduced. Due to the time frames used some children began
their investigation and management prior to the launch of the NICE
guidelines. However the guidelines were applicable at some point in
the year of follow up examined for each patient.
The approach relied on retrospective casenote analysis and
depended on written documentation as evidence of practice. The
validity of diagnoses made was not assessed by this audit.
The audit standards and performance indicators used in this
audit relate to processes within NICE and SIGN recommendations.
The indicators were designed such that higher quality care could
be inferred from a higher percentage score. Targets were not
deﬁned and for some indicators, given their deﬁnitions and the
cohort, a score of 100% may not be appropriate.
Community paediatric services were not able to be included
because these services were unable to ascertain the targetCohort 1 Cohort 2 Cohort 3 Cohort 4
43% (3/7) 67% (4/6) 33% (1/3) 67% (4/6)
0% (0/7) 0% (0/6) 0% (0/3) 83% (5/6)
44% (8/18) 25% (2/8) 50% (7/14) 52% (13/25)
100% (5/5) 100% (2/2) 100% (2/2) 100% (3/3)
90% (9/10) 83% (5/6) 63% (5/8) 88% (7/8)
100% (9/9) 80% (4/5) 100% (5/5) 86% (6/7)
71% (5/7) 33% (2/6) 0% (0/3) 67% (4/6)
100% (5/5) 50% (2/6) n/a 75% (3/4)
100% (4/4) n/a (0/0) 100% (3/3) 86% (12/14)
67% (2/3) 100% (1/1) 50% (1/2) 100% (1/1)
40% (2/5) 0% (0/1) 50% (1/2) 0% (0/5)
0% (0/1) n/a (0/0) n/a (0/0) n/a (0/0)
0% (0/5) 50% (1/2) 50% (1/2) 33% (1/3)
100% (2/2) n/a (0/0) n/a (0/0) n/a (0/0)
Table 4
Service Descriptors for each cohort and overall.
All Cohort 1 Cohort 2 Cohort 3 Cohort 4
Managed clinical network Trent Workstream Trent Workstream Trent Workstream Trent Workstream Trent Workstream
Epilepsy interest group Regional Regional Regional Regional Regional
Types of designated clinics available
to cohort.
Tertiary Satellite None Epilepsy Clinic, Young
Persons, Transition,
Seizure Clinic,
Transition
Epilepsy patients identiﬁable by service Acute/outpatient Acute Acute/outpatient Acute/outpatient
Median waiting time for ﬁrst outpatient
assessment (weeks) (range)
5.9 (0–15.4) 1.2 (0–10.7) 9.0 (8–10) 4.1 (0–15.4) 6.4(4.5–10.1)
Median waiting time for EEG (weeks)
(25–75th centile)
5.4 (3.9–8.6) 5.4 (5–6.1) 21.4 (17.4–24.7) 0.3 (0–2.6) 4.3 (2.9–5.9)
Median waiting time for MRI (weeks)
(25–75th centile)
0.3 (0–30.6) 0 (0–0.29) 14.1 (14.1–14.1) 0 (0–11.6) 22.9 (22.9–22.9)
Median waiting time for outpatient tertiary
opinion (weeks) (25–75th centile)
14.0 (11–16.9) 14.0 (11–16.9) n/a n/a n/a
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allowing a practical means of reviewing the notes.
The audit conclusions included the following:
 46% with a diagnosis of epilepsy at one year were not assessed by
a paediatrician with deﬁned expertise in epilepsy.
 there was a lack of evidence of appropriate assessment,
diagnosis, investigation and communication in 54% of children
with seizure(s).
 23% of children had an ECG where indicated according to NICE
recommendations.
 there was a lack of evidence of appropriate input from a
children’s epilepsy nurse specialist in 77% of children and there
were insufﬁcient epilepsy nurse specialists (recommended ratio
of 1 epilepsy nurse specialist to 250 children with epilepsy).9
 the median waiting times for ﬁrst outpatient assessment,
investigation and outpatient paediatric neurology opinion fell
outside NICE recommendations of 2 weeks for ﬁrst paediatric
assessment.
 it was difﬁcult for secondary services to systematically and easily
identify children with epilepsy in their care.
The audit team made the following key clinical recommenda-
tions within the Children’s Epilepsy Workstream in Trent:
Children:
1. With an epileptic seizure should have previous and current
development and/or school progress documented at ﬁrst
assessment
2. With paroxysmal episodes should have the absence or presence
of triggering or contextual factors documented
3. With convulsive episodes should have a standard 12-lead ECG
with documented calculation of QTc. This recommendation
chosen to align with SIGN guidelines as this was considered to
be more easily implementable for all children with convulsive
episodes (SIGN) as opposed to limited to those where there was
diagnostic uncertainty (NICE).
4. With any paroxysmal event should have documented evidence
of ﬁrst aid advice
5. There should be evidence of involvement of a paediatric
neurologist where appropriate.
All children with epilepsies:
1. Should have International League Against Epilepsy (ILAE)
multiaxial diagnoses where possible.10
2. All children meeting the criteria for an MRI should receive MRI.
3. Children commenced on antiepileptic medication should have
documentation of appropriate information; this should includediscussion about pregnancy and contraception in females aged
twelve and over.
Children without epilepsy:
1. Should not be treated with antiepileptic medication (unless for
another speciﬁc recognised movement or pain disorder).
2. Should not have an EEG performed (unless for another speciﬁc
disorder apart from epilepsy).
Key Service Recommendations:
1. All paediatricians involved in diagnosing, investigating and
managing children with suspected epilepsies should have
evidence of appropriate training (e.g. PET1 & PET2 or equivalent)
and participation in relevant audit.
2. Children referred with paroxysmal episodes should be offered a
ﬁrst paediatric assessment within 2 weeks.
3. EEG and MRI services should be conﬁgured to allow assessment
within a maximum of 4 weeks.
4. Paediatric services to support development of a ratio of one
epilepsy nurse specialist to approximately 250 children with
epilepsies.
5. Services should work towards systems that allow easy
identiﬁcation of patients for future audit and research purposes.
Conclusions and recommendations were used by the Children’s
Epilepsy Workstream in Trent to support an ongoing quality
improvement strategy.
5. Discussion
The audit prompted a consideration of a number of issues
regarding the practicality and effectiveness of a standardised
multi-centre audit.
In arriving at the chosen methodology for this audit, alternative
methods of reviewing quality of management had been considered.
Independent clinical review of children’s diagnosis and manage-
ment, as has been reported in previous services evaluations,11 was
considered impractical when auditing services on a national scale.
Clinical, rather than process, outcomes for children with epilepsies
might provide an ideal measure of the quality of a service. However
using clinical outcomes as an indicator for quality in a meaningful
way seemed unrealistic at this time. The diagnosis of epilepsy covers
a very heterogeneous ‘case mix’ and expected outcomes vary
dramatically from one epilepsy to another. The ascertainment of the
target population was difﬁcult and time consuming.
The results obtained by this multi-cohort audit suggest
differences in performance indicators between different centres
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undertaken. The small numbers obtained, particularly for some
performance indicators, raises difﬁculties when considering the
signiﬁcance of results and their variation. Results however were
sufﬁcient to provoke constructive discussion between different
centres within a network and highlighted areas for development
for different services. A network meeting with commissioners and
providers was arranged and action plans developed for each
service. To date ongoing audit and action plans for the region has
resulted in demonstrably more epilepsy nurses, seizure clinics,
young persons clinics and tertiary satellite clinics across the region.
Clinical data capture tools, local care pathways and standardised
letter templates have all been devised in response to audit ﬁndings
(www.cewt.org.uk).
Although prospective audit for these children would have a
number of beneﬁts there are difﬁculties with this approach.
Achieving complete ascertainment prospectively is challenging
where children are managed in an array of different generic
services. Also when prospectively auditing long term conditions a
substantial lag time can occur between patients entering the audit
and audit results. This audit demonstrated that a retrospective
methodology can produce meaningful and timely measures of
process that can inform service development.
The deﬁnition of ‘‘paediatrican with expertise’’ was subjective
and varied from cohort to cohort. A more objective deﬁnition of
paediatrician with expertise should be sought.
A second pilot using a 6 month capture period and EEG based
ascertainment was planned following this audit pilot in order to
determine the feasibility of a national audit, in terms of time
commitment from local junior professionals undertaking the
audit with a centrally-funded small project team. This further
concluded that EEG ascertainment was achievable and that an
average local cohort would require 15 h input (15 min data entry/
child).
Although the segment of audit development outlined began
over 7 years ago, the evidence base and resulting standards
deﬁning best practice have remained largely unchanged. The
timeframe shows the importance of guideline implementation
as a continuing process and how audit methodologies need
to develop and improve in order to rigorously research
quality and understand how outcomes relate to variation of
intervention.
The BPNA and RCPCH commenced in 2009 the Epilepsy12
national audit.11 This was a 3 year, Dept. of Health funded
(£500,000) national audit based on the Mid-Trent pilot and
subsequent methodology revisions.
The Epilepsy12 audit used a similar methodology with the
following adaptations informed by this Mid-Trent audit.
 Children were ascertained using ﬁrst EEG neurophysiology
databases. Those identiﬁed within a 12 month time window
were further ﬁltered to capture those who had a ﬁrst paediatric
assessment within the ﬁrst 6 months. Using EEG ascertainment allowed community paediatric ascer-
tainment.
 Providers were grouped together into pragmatic audit units and
regional tertiary units.
 ‘Paediatrician with expertise’ was deﬁned according to the
Edinburgh Consensus Conference.12
 A census day was created such that all participating audit units
aligned to describe how their services were resourced at the
same point in time.
 A patient related experience measurement tool was created.
 Data accuracy was improved by using a webtool with validation,
a data cleaning phase and kappa testing for inter-observer
variability.
 Epilepsy12 round 1 was successfully completed and published
results September 2012.11 186 audit units submitted data on a
total of approximately 5000 children.
6. Conclusions
Effective audit is an essential component to aid implementation
of national clinical guidelines and improvement in the quality of
health care. There are advantages in undertaking large scale
systematic audit as they allow variation to be captured; resource
peer-to-peer learning and inform policy at local, regional and
national tiers. There is no reason why the methodologies used in
audit should not be as robust as those used in effective clinical
research. This audit illustrates the successful evolution of a small
single centre audit to a large scale multi-centre audit for an
important and complex long term group of conditions.
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